OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways
Mina Y. George, Esther T. Menze, Ahmed Esmat, et al.
Life Sciences (2020) Vol. 249, pp. 117535-117535
Closed Access | Times Cited: 37
Mina Y. George, Esther T. Menze, Ahmed Esmat, et al.
Life Sciences (2020) Vol. 249, pp. 117535-117535
Closed Access | Times Cited: 37
Showing 1-25 of 37 citing articles:
Advantages and Limitations of Animal Schizophrenia Models
Magdalena Białoń, Agnieszka Wąsik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5968-5968
Open Access | Times Cited: 67
Magdalena Białoń, Agnieszka Wąsik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5968-5968
Open Access | Times Cited: 67
Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4/NF-kB/NLRP3 pathways
Shaimaa S. Ibrahim, Omar G. Abo Elseoud, Mohamed H. Mohamedy, et al.
Neuropharmacology (2021) Vol. 197, pp. 108738-108738
Closed Access | Times Cited: 57
Shaimaa S. Ibrahim, Omar G. Abo Elseoud, Mohamed H. Mohamedy, et al.
Neuropharmacology (2021) Vol. 197, pp. 108738-108738
Closed Access | Times Cited: 57
Insights into the neuroprotective effects ofSalvia officinalisL. andSalvia microphyllaKunth in the memory impairment rat model
Iriny M. Ayoub, Mina Y. George, Esther T. Menze, et al.
Food & Function (2022) Vol. 13, Iss. 4, pp. 2253-2268
Closed Access | Times Cited: 37
Iriny M. Ayoub, Mina Y. George, Esther T. Menze, et al.
Food & Function (2022) Vol. 13, Iss. 4, pp. 2253-2268
Closed Access | Times Cited: 37
Chemical characterization of the polyphenolic rich fraction of Thunbergia erecta and its therapeutic potential against doxorubicin and cyclophosphamide-induced cognitive impairment in rats
Mariam I. Gamal El‐Din, Mina Y. George, Fadia S. Youssef
Journal of Ethnopharmacology (2023) Vol. 307, pp. 116213-116213
Closed Access | Times Cited: 31
Mariam I. Gamal El‐Din, Mina Y. George, Fadia S. Youssef
Journal of Ethnopharmacology (2023) Vol. 307, pp. 116213-116213
Closed Access | Times Cited: 31
Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence
Heba H. Awad, Mahmoud A. Desouky, Alaa Zidan, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2653-2673
Open Access | Times Cited: 26
Heba H. Awad, Mahmoud A. Desouky, Alaa Zidan, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2653-2673
Open Access | Times Cited: 26
Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways
Noha Nabil Mohammed, Mariane G. Tadros, Mina Y. George
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 777-794
Open Access | Times Cited: 19
Noha Nabil Mohammed, Mariane G. Tadros, Mina Y. George
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 777-794
Open Access | Times Cited: 19
Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1
Yan Xi, Zhongchao Chi, Xufeng Tao, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1153-1161
Open Access | Times Cited: 16
Yan Xi, Zhongchao Chi, Xufeng Tao, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1153-1161
Open Access | Times Cited: 16
L-carnitine Modulates Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights to Oxidative Stress, Inflammation, Synaptic Plasticity, Liver/brain, and Kidney/brain Axes
Olivia Fayez Morid, Esther T. Menze, Mariane G. Tadros, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 3, pp. 310-326
Open Access | Times Cited: 16
Olivia Fayez Morid, Esther T. Menze, Mariane G. Tadros, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 3, pp. 310-326
Open Access | Times Cited: 16
Implication of Wnt/GSK-3β/β-Catenin Signaling in the Pathogenesis of Mood Disturbances Associated with Hyperthyroidism in Rats: Potential Therapeutic Effect of Naringin
Mai A. Abd‐Elmawla, Reham M. Essam, Kawkab A. Ahmed, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2035-2048
Closed Access | Times Cited: 14
Mai A. Abd‐Elmawla, Reham M. Essam, Kawkab A. Ahmed, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 2035-2048
Closed Access | Times Cited: 14
NMDA receptor modulation by Esculetin: Investigating behavioral, biochemical and neurochemical effects in schizophrenic mice model
Iqra Khalid, Uzma Saleem, Bashir Ahmad, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 4, pp. 101994-101994
Open Access | Times Cited: 4
Iqra Khalid, Uzma Saleem, Bashir Ahmad, et al.
Saudi Pharmaceutical Journal (2024) Vol. 32, Iss. 4, pp. 101994-101994
Open Access | Times Cited: 4
Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
Investigating the therapeutic potential of naringin in MK-801-induced schizophrenia Model: Focus on cognitive impairment and miR-25-3p-Regulated Pathways
Y. N. Pu, Yiyong Xu, Zushun Zhuo, et al.
International Journal of Neuroscience (2025), pp. 1-23
Closed Access
Y. N. Pu, Yiyong Xu, Zushun Zhuo, et al.
International Journal of Neuroscience (2025), pp. 1-23
Closed Access
Niacin mitigates blood–brain barrier tight junctional proteins dysregulation and cerebral inflammation in ketamine rat model of psychosis: Role of GPR109A receptor
Weam W. Ibrahim, Rabab H. Sayed, Esraa A. Kandil, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110583-110583
Closed Access | Times Cited: 21
Weam W. Ibrahim, Rabab H. Sayed, Esraa A. Kandil, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110583-110583
Closed Access | Times Cited: 21
Design and evaluation of chrysin-loaded nanoemulsion against lithium/pilocarpine-induced status epilepticus in rats; emphasis on formulation, neuronal excitotoxicity, oxidative stress, microglia polarization, and AMPK/SIRT-1/PGC-1α pathway
Mina Y. George, Marwa O. El-Derany, Yasmine Ahmed, et al.
Expert Opinion on Drug Delivery (2022) Vol. 20, Iss. 1, pp. 159-174
Closed Access | Times Cited: 19
Mina Y. George, Marwa O. El-Derany, Yasmine Ahmed, et al.
Expert Opinion on Drug Delivery (2022) Vol. 20, Iss. 1, pp. 159-174
Closed Access | Times Cited: 19
Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axes
Diana M. F. Hanna, John Youshia, Sarah Fahmy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1859-1873
Open Access | Times Cited: 12
Diana M. F. Hanna, John Youshia, Sarah Fahmy, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1859-1873
Open Access | Times Cited: 12
LC-qTOF-MS/MS phytochemical profiling of Tabebuia impetiginosa (Mart. Ex DC.) Standl. leaf and assessment of its neuroprotective potential in rats
Nesma Khaled, Nehal Ibrahim, Alaa E. Ali, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118292-118292
Closed Access | Times Cited: 3
Nesma Khaled, Nehal Ibrahim, Alaa E. Ali, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118292-118292
Closed Access | Times Cited: 3
Naringin Ameliorates Haloperidol-Induced Neurotoxicity and Orofacial Dyskinesia in a Rat Model of Human Tardive Dyskinesia
Mao‐Hsien Wang, Chih-Chuan Yang, Hsiang-Chien Tseng, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 3, pp. 774-786
Closed Access | Times Cited: 18
Mao‐Hsien Wang, Chih-Chuan Yang, Hsiang-Chien Tseng, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 3, pp. 774-786
Closed Access | Times Cited: 18
Neuronal alterations in AKT isotype expression in schizophrenia
Emily A. Devine, Ali Sajid Imami, Hunter Eby, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 2
Emily A. Devine, Ali Sajid Imami, Hunter Eby, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 2
Alternative Therapy of Psychosis: Potential Phytochemicals and Drug Targets in the Management of Schizophrenia
Ammara Saleem, Qurat-ul-Ain Qurat-ul-Ain, Muhammad Furqan Akhtar
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Ammara Saleem, Qurat-ul-Ain Qurat-ul-Ain, Muhammad Furqan Akhtar
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 12
Micronization of naringenin in supercritical fluid medium: In vitro and in vivo assays
Patrícia Viera de Oliveira, Otávio Sanaiotto, Ketelin Z. Kuhn, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104382-104382
Closed Access | Times Cited: 6
Patrícia Viera de Oliveira, Otávio Sanaiotto, Ketelin Z. Kuhn, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104382-104382
Closed Access | Times Cited: 6
Effect of Naringin Treatment on Postmenopausal Osteoporosis in Ovariectomized Rats: A Meta-Analysis and Systematic Review
Zhu Zhu, Wenjing Xie, Yanyan Li, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 13
Zhu Zhu, Wenjing Xie, Yanyan Li, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 13
Meticulous parade on naringin respecting its pharmacological activities and novel formulations.
Mahboob Alam, Farogh Ahsan, Tarique Mahmood, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 12, Iss. 5, pp. 457-474
Closed Access | Times Cited: 9
Mahboob Alam, Farogh Ahsan, Tarique Mahmood, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2022) Vol. 12, Iss. 5, pp. 457-474
Closed Access | Times Cited: 9
Neuronal alterations in AKT isotype expression in schizophrenia
Robert E. McCullumsmith, Ali Sajid Imami, Hunter Eby, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Robert E. McCullumsmith, Ali Sajid Imami, Hunter Eby, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Pharmacological screening of silibinin for antischizophrenic activity along with its acute toxicity evaluation in experimental animals
Qurat Ul Ain, Uzma Saleem, Bashir Ahmad, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Qurat Ul Ain, Uzma Saleem, Bashir Ahmad, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis
Reut Hazani, Michal Lavidor, Aron Weller
Schizophrenia Bulletin (2022) Vol. 48, Iss. 6, pp. 1179-1193
Open Access | Times Cited: 7
Reut Hazani, Michal Lavidor, Aron Weller
Schizophrenia Bulletin (2022) Vol. 48, Iss. 6, pp. 1179-1193
Open Access | Times Cited: 7
